• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Zura Bio Limited - Class A Ordinary shares (NQ: ZURA )

    4.260 UNCHANGED
    Streaming Delayed Price Updated: 4:00 PM EDT, Aug 27, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 500
    Open 4.260
    Bid (Size) 4.260 (19)
    Ask (Size) 5.500 (12)
    Prev. Close 4.260
    Today's Range 4.260 - 4.260
    52wk Range 2.000 - 7.400
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    ZURA Stock Earnings: Zura Bio Misses EPS for Q2 2024
    ZURA stock results show that Zura Bio missed analyst estimates for earnings per share the second quarter of 2024. 
    Via InvestorPlace
    Zura Bio Reports Second Quarter 2024 Financial Results and Recent Business Highlights
    From Zura Bio Limited
    Via Business Wire

    Performance

    YTD
    -2.07%
    -2.07%
    1 Month
    +5.97%
    +5.97%
    3 Month
    -18.86%
    -18.86%
    6 Month
    +15.14%
    +15.14%
    1 Year
    -36.70%
    -36.70%

    More News

    Read More
    Zura Bio Completes Exchange Offer and Consent Solicitation and Notice to Exercise Right to Exchange Remaining Outstanding Warrants
    From Zura Bio Limited
    Via Business Wire
    ZURA Stock Earnings: Zura Bio Beats EPS for Q2 2024
    Via InvestorPlace
    Zura Bio Announces Expiration and Results of Exchange Offer and Consent Solicitation Relating to its Warrants
    From Zura Bio Limited
    Via Business Wire
    Sagimet Biosciences Announces Appointment of Anne Phillips and Jennifer Jarrett to its Board of Directors
    From Sagimet Biosciences Inc.
    Via GlobeNewswire
    3 Undervalued Biotech Stocks With Breakout Potential
    Via InvestorPlace
    Zura Bio Commences Warrant Exchange Offer and Consent Solicitation
    From Zura Bio Limited
    Via Business Wire
    The 3 Most Undervalued Biotech Stocks to Buy in July 2024
    Via InvestorPlace
    Zura Bio Presents Data for the Tibulizumab (ZB-106) Program at EULAR 2024
    From Zura Bio Limited
    Via Business Wire
    Zura Bio Forms Scientific Advisory Board with Prominent Specialists in Rheumatology, Dermatology, and Immunology
    From Zura Bio Limited
    Via Business Wire
    Zura Bio to Present Data Exploring the Expanded Potential of Tibulizumab (ZB-106) into Sjogren's Syndrome and Rheumatoid Arthritis at EULAR 2024
    From Zura Bio Limited
    Via Business Wire
    Zura Bio Announces Participation in June Investor Conferences
    From Zura Bio Limited
    Via Business Wire
    3 Penny Stocks to Buy Now: May 2024
    Via InvestorPlace
    Zura Bio Reports First Quarter 2024 Financial Results and Recent Business Highlights
    From Zura Bio Limited
    Via Business Wire
    12 Health Care Stocks Moving In Friday's Intraday Session
    Via Benzinga
    Zura Bio Announces Oversubscribed $112.5 Million Private Placement
    From Zura Bio
    Via Business Wire
    Zura Bio Announces Robert Lisicki as CEO and Director
    From Zura Bio Limited
    Via Business Wire
    ZURA Stock Earnings: Zura Bio Misses EPS for Q4 2023
    Via InvestorPlace
    Zura Bio Reports Full Year 2023 Financial Results, Business Highlights, and Appoints Robert Lisicki as Chief Executive Officer
    From Zura Bio Limited
    Via Business Wire
    12 Health Care Stocks Moving In Friday's Intraday Session
    Via Benzinga
    Zura Bio Announces Participation at March Conferences
    From Zura Bio Limited
    Via Business Wire
    Zura Bio Announces Participation at February Investor Conferences
    From Zura Bio Limited
    Via Business Wire
    Zura Bio Continues to Strengthen Leadership with Appointment of Robert Lisicki as President and Kiran Nistala as CMO
    From Zura Bio Limited
    Via Business Wire
    Zura Bio to Present at the 42nd Annual J.P. Morgan Healthcare Conference and Dermatology Summit
    From Zura Bio Limited
    Via Business Wire
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.